Perioperative medicine & outcomes

The Air-Test score for prediction of postoperative pulmonary complications after general anaesthesia: analysis of harmonised trial data and a prospective observational cohort

Br J AnaesthPublished Secondary analysis of harmonised data from three multicentre RCTs and a prospective observational study

Authors' conclusion

The Air-Test is a simple noninvasive bedside score with a good performance in identifying patients after major surgery who will not develop severe PPCs.

Study context

Population
Surgical patients undergoing GA3 multicentre RCTs and a prospective observational study
Participants
3,268 patients
Comparison
Positive vs negative Air-Test for prediction of severe postoperative pulmonary complications (PPCs)
  • Trainingn = 2,288
  • Validationn = 980
Primary endpoint
Composite of severe PPCs
Follow-up
First 7 postoperative days
Methodological detailsdiagnostic/prognostic accuracy, random split into training and validation cohorts
  • Diagnostic/prognostic accuracy
  • Random split into training and validation cohorts

Primary result

As reported in the abstract

Severe PPCs, positive vs negative Air-Test · 7 days
Odds ratio (95% CI)P value
Positive Air-Test (Training) vs Negative Air-Test
1.85(1.21–3.15)
P = 0.007
Positive Air-Test (Validation) vs Negative Air-Test
2.27(1.27–4.61)
P = 0.011
AUC for detecting PPCs, similar in both cohorts (printed as OR)
0.57 (95% CI 0.50-0.64)
Sensitivity, each cohort
53-54%
Specificity, each cohort
59-60%
PPV, each cohort
6-8%
NPV, each cohort
95-96%

Further findings

Incidence of severe PPCs within 7 days (all participants)

Severe PPCs
164/3268 (5.0%)

Original publication

The Air-Test score for prediction of postoperative pulmonary complications after general anaesthesia: analysis of harmonised trial data and a prospective observational cohort. Br J Anaesth. Published 17 December 2025. doi:10.1016/j.bja.2025.11.010

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.